vs

Side-by-side financial comparison of LendingClub Corp (LC) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

LendingClub Corp is the larger business by last-quarter revenue ($252.3M vs $225.6M, roughly 1.1× Organogenesis Holdings Inc.). LendingClub Corp runs the higher net margin — 20.5% vs 19.4%, a 1.1% gap on every dollar of revenue. On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs 15.9%). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs 16.1%).

LendingClub Corporation is an American financial services company headquartered in San Francisco, California. It was the first peer-to-peer lender to register its offerings as securities with the Securities and Exchange Commission (SEC), and to offer loan trading on a secondary market. At its height, LendingClub was the world's largest peer-to-peer lending platform. The company reported that $15.98 billion in loans had been originated through its platform up to December 31, 2015.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

LC vs ORGO — Head-to-Head

Bigger by revenue
LC
LC
1.1× larger
LC
$252.3M
$225.6M
ORGO
Growing faster (revenue YoY)
ORGO
ORGO
+62.2% gap
ORGO
78.1%
15.9%
LC
Higher net margin
LC
LC
1.1% more per $
LC
20.5%
19.4%
ORGO
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
16.1%
LC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
LC
LC
ORGO
ORGO
Revenue
$252.3M
$225.6M
Net Profit
$51.6M
$43.7M
Gross Margin
Operating Margin
28.1%
Net Margin
20.5%
19.4%
Revenue YoY
15.9%
78.1%
Net Profit YoY
341.0%
469.5%
EPS (diluted)
$0.44
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LC
LC
ORGO
ORGO
Q1 26
$252.3M
Q4 25
$266.5M
$225.6M
Q3 25
$266.2M
$150.9M
Q2 25
$248.4M
$101.0M
Q1 25
$217.7M
$86.7M
Q4 24
$217.2M
$126.7M
Q3 24
$201.9M
$115.2M
Q2 24
$187.2M
$130.2M
Net Profit
LC
LC
ORGO
ORGO
Q1 26
$51.6M
Q4 25
$43.7M
Q3 25
$44.3M
$21.6M
Q2 25
$38.2M
$-9.4M
Q1 25
$11.7M
$-18.8M
Q4 24
$7.7M
Q3 24
$14.5M
$12.3M
Q2 24
$14.9M
$-17.0M
Gross Margin
LC
LC
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
LC
LC
ORGO
ORGO
Q1 26
Q4 25
18.8%
28.1%
Q3 25
21.5%
13.7%
Q2 25
21.7%
-12.5%
Q1 25
7.2%
-30.9%
Q4 24
5.1%
8.1%
Q3 24
8.9%
5.4%
Q2 24
10.4%
-10.7%
Net Margin
LC
LC
ORGO
ORGO
Q1 26
20.5%
Q4 25
19.4%
Q3 25
16.6%
14.3%
Q2 25
15.4%
-9.3%
Q1 25
5.4%
-21.7%
Q4 24
6.1%
Q3 24
7.2%
10.7%
Q2 24
8.0%
-13.1%
EPS (diluted)
LC
LC
ORGO
ORGO
Q1 26
$0.44
Q4 25
$0.36
$0.31
Q3 25
$0.37
$0.11
Q2 25
$0.33
$-0.10
Q1 25
$0.10
$-0.17
Q4 24
$0.08
$0.05
Q3 24
$0.13
$0.09
Q2 24
$0.13
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LC
LC
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$93.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.5B
$300.1M
Total Assets
$11.9B
$598.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LC
LC
ORGO
ORGO
Q1 26
Q4 25
$93.7M
Q3 25
$63.7M
Q2 25
$73.1M
Q1 25
$110.0M
Q4 24
$135.6M
Q3 24
$94.3M
Q2 24
$89.9M
Total Debt
LC
LC
ORGO
ORGO
Q1 26
Q4 25
$0
Q3 25
$0
Q2 25
$0
Q1 25
$0
Q4 24
$0
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
LC
LC
ORGO
ORGO
Q1 26
$1.5B
Q4 25
$1.5B
$300.1M
Q3 25
$1.5B
$255.1M
Q2 25
$1.4B
$233.2M
Q1 25
$1.4B
$242.9M
Q4 24
$1.3B
$262.9M
Q3 24
$1.3B
$278.5M
Q2 24
$1.3B
$263.5M
Total Assets
LC
LC
ORGO
ORGO
Q1 26
$11.9B
Q4 25
$11.6B
$598.7M
Q3 25
$11.1B
$509.8M
Q2 25
$10.8B
$461.1M
Q1 25
$10.5B
$467.4M
Q4 24
$10.6B
$497.9M
Q3 24
$11.0B
$446.3M
Q2 24
$9.6B
$443.2M
Debt / Equity
LC
LC
ORGO
ORGO
Q1 26
Q4 25
0.00×
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LC
LC
ORGO
ORGO
Operating Cash FlowLast quarter
$39.4M
Free Cash FlowOCF − Capex
$34.8M
FCF MarginFCF / Revenue
15.4%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
0.90×
TTM Free Cash FlowTrailing 4 quarters
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LC
LC
ORGO
ORGO
Q1 26
Q4 25
$-2.7B
$39.4M
Q3 25
$-770.8M
$3.1M
Q2 25
$-713.1M
$-32.9M
Q1 25
$-339.3M
$-19.9M
Q4 24
$-2.6B
$10.9M
Q3 24
$-669.8M
$8.7M
Q2 24
$-932.5M
$4.7M
Free Cash Flow
LC
LC
ORGO
ORGO
Q1 26
Q4 25
$-2.9B
$34.8M
Q3 25
$-791.8M
$844.0K
Q2 25
$-803.8M
$-36.5M
Q1 25
$-352.3M
$-23.6M
Q4 24
$-2.7B
$7.6M
Q3 24
$-682.3M
$6.1M
Q2 24
$-945.3M
$2.9M
FCF Margin
LC
LC
ORGO
ORGO
Q1 26
Q4 25
-1076.0%
15.4%
Q3 25
-297.4%
0.6%
Q2 25
-323.5%
-36.1%
Q1 25
-161.8%
-27.2%
Q4 24
-1237.8%
6.0%
Q3 24
-338.0%
5.3%
Q2 24
-504.9%
2.2%
Capex Intensity
LC
LC
ORGO
ORGO
Q1 26
Q4 25
52.7%
2.1%
Q3 25
7.9%
1.5%
Q2 25
36.5%
3.6%
Q1 25
6.0%
4.2%
Q4 24
25.0%
2.7%
Q3 24
6.2%
2.2%
Q2 24
6.9%
1.4%
Cash Conversion
LC
LC
ORGO
ORGO
Q1 26
Q4 25
0.90×
Q3 25
-17.41×
0.14×
Q2 25
-18.68×
Q1 25
-29.07×
Q4 24
1.43×
Q3 24
-46.33×
0.71×
Q2 24
-62.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons